These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33554867)

  • 1. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
    Dalwadi DA; Torrens L; Abril-Fornaguera J; Pinyol R; Willoughby C; Posey J; Llovet JM; Lanciault C; Russell DW; Grompe M; Naugler WE
    Mol Ther; 2021 Feb; 29(2):680-690. PubMed ID: 33554867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
    Kim GY; Lee YM; Kwon JH; Cho JH; Pan CJ; Starost MF; Mansfield BC; Chou JY
    Mol Genet Metab; 2017 Mar; 120(3):229-234. PubMed ID: 28096054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.
    Li Y; Miller CA; Shea LK; Jiang X; Guzman MA; Chandler RJ; Ramakrishnan SM; Smith SN; Venditti CP; Vogler CA; Ory DS; Ley TJ; Sands MS
    Mol Ther; 2021 Feb; 29(2):691-701. PubMed ID: 33388420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents.
    Peng D; Qian C; Sun Y; Barajas MA; Prieto J
    J Hepatol; 2000 Jun; 32(6):975-85. PubMed ID: 10898318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.
    Zhong L; Malani N; Li M; Brady T; Xie J; Bell P; Li S; Jones H; Wilson JM; Flotte TR; Bushman FD; Gao G
    Hum Gene Ther; 2013 May; 24(5):520-5. PubMed ID: 23621841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.
    Donsante A; Vogler C; Muzyczka N; Crawford JM; Barker J; Flotte T; Campbell-Thompson M; Daly T; Sands MS
    Gene Ther; 2001 Sep; 8(17):1343-6. PubMed ID: 11571571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
    Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA
    Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
    Sabatino DE; Bushman FD; Chandler RJ; Crystal RG; Davidson BL; Dolmetsch R; Eggan KC; Gao G; Gil-Farina I; Kay MA; McCarty DM; Montini E; Ndu A; Yuan J;
    Mol Ther; 2022 Aug; 30(8):2646-2663. PubMed ID: 35690906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.
    Cho JH; Lee YM; Starost MF; Mansfield BC; Chou JY
    J Inherit Metab Dis; 2019 May; 42(3):459-469. PubMed ID: 30637773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
    Chandler RJ; LaFave MC; Varshney GK; Trivedi NS; Carrillo-Carrasco N; Senac JS; Wu W; Hoffmann V; Elkahloun AG; Burgess SM; Venditti CP
    J Clin Invest; 2015 Feb; 125(2):870-80. PubMed ID: 25607839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.
    Hadi M; Qutaiba B Allela O; Jabari M; Jasoor AM; Naderloo O; Yasamineh S; Gholizadeh O; Kalantari L
    Virol J; 2024 Jan; 21(1):17. PubMed ID: 38216938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of rAAV-Mediated Expression of Myostatin Propeptide Lowers Type 2 Diabetes Incidence in
    Yan H; Meng J; Zhang S; Zhuang H; Song Y; Xiao X; Wang DW; Jiang J
    Hum Gene Ther; 2019 May; 30(5):661-671. PubMed ID: 30526118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis.
    Schäffer AA; Dominguez DA; Chapman LM; Gertz EM; Budhu A; Forgues M; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Wu X; Bayarsaikhan E; Harris CC; Ruchirawat M; Ruppin E; Wang XW
    BMC Genomics; 2021 Nov; 22(1):814. PubMed ID: 34763675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway.
    Davidoff AM; Ng CY; Zhou J; Spence Y; Nathwani AC
    Blood; 2003 Jul; 102(2):480-8. PubMed ID: 12637328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.
    Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF
    World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
    Song Q; Zhang X; Liu W; Wei H; Liang W; Zhou Y; Ding Y; Ji F; Ho-Kwan Cheung A; Wong N; Yu J
    J Hepatol; 2023 Dec; 79(6):1352-1365. PubMed ID: 37459922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalent and Disseminated Recombinant and Wild-Type Adeno-Associated Virus Integration in Macaques and Humans.
    Martins KM; Breton C; Zheng Q; Zhang Z; Latshaw C; Greig JA; Wilson JM
    Hum Gene Ther; 2023 Nov; 34(21-22):1081-1094. PubMed ID: 37930949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.
    Tse LY; Sun X; Jiang H; Dong X; Fung PW; Farzaneh F; Xu R
    J Gene Med; 2008 May; 10(5):508-17. PubMed ID: 18338836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable transduction of the neonatal mouse liver using a hybrid rAAV/sleeping beauty transposon gene delivery system.
    Cunningham SC; Zakas PM; Sasaki N; van Dijk EB; Zhu E; Fu Y; Salomon WE; Citorik RJ; Rubens JR; Cotta-Ramusino C; Querbes W; Alexander IE
    J Gene Med; 2024 Aug; 26(8):e3726. PubMed ID: 39160647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.